Avacta reports 'excellent' results for test which aims to reduce spread of COVID-19

Avacta Group today announced that it has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK.

In a statement, Avacta said: "These data show excellent performance of the test in identifying patients with an infectious viral load and no false positive results."

Avacta's SARS-CoV-2 rapid antigen test has been developed to identify infectious individuals so that they can isolate promptly and reduce the spread of COVID-19.

Avacta said: "The initial evaluation of Avacta's lateral flow rapid antigen test with clinical samples has been carried out at two sites, one in the EU and one in the UK using patient samples with viral loads.

"On the basis of these excellent initial data, the company will now progress to a full clinical validation with a larger number of patient samples to CE mark the test for professional use, aiming to bring the test to market in Europe around the end of the first quarter of this year.

Dr Alastair Smith, chief executive officer of Avacta Group, commented: "I am delighted with the performance of the test with clinical samples which is extremely encouraging.

"On the basis of these initial clinical studies, the lateral flow test shows very good sensitivity in the infectious range of viral loads including at the lower infectious loads with Ct values of 23-26 which compares very favourably with the data reported in the Liverpool Covid SMART Pilot Study report.

"These data from the first clinical studies will allow us to quickly progress with confidence into the full clinical validation of the test, manufactured at scale, at our clinical trial sites in the UK and the EU. I am confident that these data will accelerate our commercial discussions regarding the roll-out of the test when it is approved for professional use."

"I look forward to updating the market on clinical and commercial progress in due course."

Support The Yorkshire Post and become a subscriber today. Your subscription will help us to continue to bring quality news to the people of Yorkshire. In return, you'll see fewer ads on site, get free access to our app and receive exclusive members-only offers. Click here to subscribe.